These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 6225980)

  • 21. Exodontia in combined factor V and factor VIII deficiency.
    Bartlett JA; Sweeney JD; Sadowsky D
    J Oral Maxillofac Surg; 1985 Jul; 43(7):537-9. PubMed ID: 3159861
    [No Abstract]   [Full Text] [Related]  

  • 22. Correlation between factor VIII genotype and inhibitor development in hemophilia A.
    Fakharzadeh SS; Kazazian HH
    Semin Thromb Hemost; 2000; 26(2):167-71. PubMed ID: 10919409
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Circulating antibodies in factor VIII deficiency hemophilia: report of case.
    Cudzinowski L
    ASDC J Dent Child; 1979; 46(1):54-6. PubMed ID: 283081
    [No Abstract]   [Full Text] [Related]  

  • 24. Effect of prothrombin complex concentrates on factor VIII inhibitor levels.
    Kasper CK
    Blood; 1979 Dec; 54(6):1358-68. PubMed ID: 508942
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anaphylactic reactions following infusion of factor VIII in a patient with classic hemophilia.
    Helmer RE; Alperin JB; Yunginger JW; Grant JA
    Am J Med; 1980 Dec; 69(6):953-7. PubMed ID: 6160766
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gene Delivery of Activated Factor VII Using Alternative Adeno-Associated Virus Serotype Improves Hemostasis in Hemophiliac Mice with FVIII Inhibitors and Adeno-Associated Virus Neutralizing Antibodies.
    Sun J; Hua B; Chen X; Samulski RJ; Li C
    Hum Gene Ther; 2017 Aug; 28(8):654-666. PubMed ID: 28478688
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hemophilia and von Willebrand's disease: 2. Management. Association of Hemophilia Clinic Directors of Canada.
    CMAJ; 1995 Jul; 153(2):147-57. PubMed ID: 7600466
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibitors of factor VIII: detection and treatment.
    Brettler DB
    Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():21-5. PubMed ID: 7886576
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The prevalence of proteolytic antibodies against factor VIII in hemophilia A.
    Lacroix-Desmazes S; Bayry J; Misra N; Horn MP; Villard S; Pashov A; Stieltjes N; d'Oiron R; Saint-Remy JM; Hoebeke J; Kazatchkine MD; Reinbolt J; Mohanty D; Kaveri SV
    N Engl J Med; 2002 Feb; 346(9):662-7. PubMed ID: 11870243
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of the bleeding inhibitor patient.
    Astermark J
    Semin Thromb Hemost; 2003 Feb; 29(1):77-86. PubMed ID: 12640569
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Devastative tongue bleeding due to self-bite after dental extraction in a haemophilia A patient with inhibitor.
    Karagun BS; Sasmaz I; Antmen B; Kilinc Y; Gulec S; Ciftci V; Dogan MC
    Haemophilia; 2014 Mar; 20(2):e177-9. PubMed ID: 24533957
    [No Abstract]   [Full Text] [Related]  

  • 32. Elective cardiac operation in a patient with severe hemophilia and acquired factor VIII antibodies.
    Leggett PL; Doyle D; Smith WB; Culpepper W; Cooper S; Ochsner JL
    J Thorac Cardiovasc Surg; 1984 Apr; 87(4):556-60. PubMed ID: 6423912
    [TBL] [Abstract][Full Text] [Related]  

  • 33. DDAVP: review of indications for its use in the treatment of factor VIII deficiency and report of a case.
    Eastman JR; Nowakowski AR; Triplett DA
    Oral Surg Oral Med Oral Pathol; 1983 Sep; 56(3):246-51. PubMed ID: 6226910
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serial plasmapheresis in a haemophiliac with antibodies to FVIII.
    Cobcroft R; Tamagnini G; Dormandy KM
    J Clin Pathol; 1977 Aug; 30(8):763-5. PubMed ID: 599190
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Properties of anti-factor VIII inhibitor antibodies in hemophilia A patients.
    Scandella DH
    Semin Thromb Hemost; 2000; 26(2):137-42. PubMed ID: 10919405
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tolerance to factor VIII inhibitors in hemophilia A patients: a French twist.
    Pascual V; Capra JD
    J Clin Invest; 1996 Mar; 97(6):1357-8. PubMed ID: 8617864
    [No Abstract]   [Full Text] [Related]  

  • 37. Dental hygiene care for the hemophilia A patient. Case report.
    Tvrdy JL; Muzzin KB
    J Dent Hyg; 1990 Mar; 64(3):126-31. PubMed ID: 2149147
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The treatment of factor VIII inhibitors--a general overview.
    White GC; Roberts HR
    Vox Sang; 1996; 70 Suppl 1():19-23. PubMed ID: 8869464
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence of factor VIII inhibitors in patients with hemophilia A in Brazil.
    Rieger A; Roisenberg I
    Thromb Haemost; 1999 Mar; 81(3):475-6. PubMed ID: 10102489
    [No Abstract]   [Full Text] [Related]  

  • 40. Fatal myocardial infarction following therapy with prothrombin complex concentrates in a young man with hemophilia A.
    Sullivan DW; Purdy LJ; Billingham M; Glader BE
    Pediatrics; 1984 Aug; 74(2):279-81. PubMed ID: 6431390
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.